BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38433058)

  • 1. [Colorectal cancer with β-catenin protein expression deficiency: a clinicopathological analysis].
    Zhang YY; Xin X; Bi LQ; Shi FY; Cao RX; Wang YM; Liu XH
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):288-292. PubMed ID: 38433058
    [No Abstract]   [Full Text] [Related]  

  • 2. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
    Escobar D; Bushara O; Sun L; Liao J; Yang GY
    Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort.
    Tan LP; Ng BK; Balraj P; Lim PK; Peh SC
    Pathology; 2007 Apr; 39(2):228-34. PubMed ID: 17454753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
    Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
    Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of Axin and beta-catenin in non-small cell lung cancer].
    Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
    Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY
    World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and mutation pattern of β-catenin and adenomatous polyposis coli in colorectal cancer patients.
    Abdelmaksoud-Damak R; Miladi-Abdennadher I; Triki M; Khabir A; Charfi S; Ayadi L; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
    Arch Med Res; 2015 Jan; 46(1):54-62. PubMed ID: 25660336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
    Matsushima J; Yazawa T; Suzuki M; Takahashi Y; Ota S; Nakajima T; Yoshino I; Yokose T; Inoue T; Kawahara K; Nakatani Y
    Hum Pathol; 2017 Jun; 64():179-185. PubMed ID: 28438615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Real-time PCR analysis of beta-catenin mRNA in sporadic colorectal cancers].
    Qin YJ; Zhou XY; Cai SJ; Yan G; Zhang TM; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):535-9. PubMed ID: 17134547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations of the CTNNA1 and the CTNNB1 genes in sporadic colorectal cancer in Polish population.
    Sygut A; Przybyłowska K; Ferenc T; Dziki Ł; Spychalski M; Mik M; Dziki A
    Pol Przegl Chir; 2012 Nov; 84(11):560-4. PubMed ID: 23399619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Catenin accumulation and S33F mutation of CTNNB1 gene in colorectal cancer in Saudi Arabia.
    Alomar SY; Mansour L; Abuderman A; Alkhuriji A; Arafah M; Alwasel S; Harrath AH; Almutairi M; Trayhyrn P; Dar JA
    Pol J Pathol; 2016 Jun; 67(2):156-62. PubMed ID: 27543871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The majority of β-catenin mutations in colorectal cancer is homozygous.
    Arnold A; Tronser M; Sers C; Ahadova A; Endris V; Mamlouk S; Horst D; Möbs M; Bischoff P; Kloor M; Bläker H
    BMC Cancer; 2020 Oct; 20(1):1038. PubMed ID: 33115416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.
    Hao L; Zhao Y; Wang Z; Yin H; Zhang X; He T; Song S; Sun S; Wang B; Li Z; Su Q
    J Mol Histol; 2016 Apr; 47(2):117-28. PubMed ID: 26779651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of the immunohistochemical expression and mutational pattern of the key mediator of Wnt signaling: beta-catenin in Tunisian patients with colorectal carcinoma.
    Khiari M; Arfaoui A; Kriaa L; Chaar I; Amara S; Lounis MA; Sammoud S; Dhraeif M; Gharbi L; Mzabi-Regaya S; Bouraoui S
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):62-70. PubMed ID: 21602666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 cases.
    Thomas de Montpréville V; Lacroix L; Rouleau E; Mamodaly M; Leclerc J; Tutuianu L; Planchard D; Boulate D; Mercier O; Besse B; Fadel É; Ghigna MR
    Ann Diagn Pathol; 2020 Jun; 46():151522. PubMed ID: 32442860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.
    El Agy F; El Bardai S; El Otmani I; Benbrahim Z; Karim MH; Mazaz K; Benjelloun EB; Ousadden A; El Abkari M; Ibrahimi SA; Chbani L
    PLoS One; 2021; 16(3):e0248522. PubMed ID: 33784337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.